NEURIVE

NEURIVE is a promising startup, positioning itself as a front runner for digital medical platforms. Established in 2018, the company focuses on developing cutting-edge technologies tailored to the specific needs of the medical sector. Its core expertise lies in the creation of electroceuticals and digital medical treatment devices. NEURIVE's primary area of interest is non-invasive vagus nerve stimulation technology, and the company's research and development efforts are directed towards the advancement of electroceuticals and other innovative technologies to revolutionize medical devices and medicine. Headquartered in South Korea, NEURIVE recently secured a significant milestone by raising a KRW1.00B Seed Round investment on 26 September 2021. The noteworthy participation of investors such as Magna Investment, SL Investment, and the Korea Entrepreneurship Foundation reflects the industry's confidence in the potential of NEURIVE's innovative concept and technology. With its strong focus on addressing the evolving needs of the medical field, NEURIVE's value proposition holds great promise for the future of digital medical platforms.